close
MENU
Investment
3 mins to read

‘Please explain’ from Blis remains unanswered by one party

‘I don’t want to become an expert in this area, that’s for sure,’ CEO says about patent dispute.

Blis Probiotics has been in contact with one party but not the other regarding a disputed patent.

Kate McVicar Mon, 30 Sep 2024

 A ‘please explain’ discussion request over a disputed patent has yielded mixed results, with one party yet to respond.

More information came to light on Friday regarding the disputed patent filing for fermentation processes claimed by Blis Technologies.

Two executives from Bluestone Pharma – a

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Kate McVicar Mon, 30 Sep 2024
Contact the Writer: kate@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Company profile
Powered by:
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
‘Please explain’ from Blis remains unanswered by one party
Investment,
106050
true